Growth Metrics

Bioventus (BVS) Interest & Investment Income (2020 - 2026)

Bioventus filings provide 6 years of Interest & Investment Income readings, the most recent being -$5.3 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 41.02% to -$5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$26.5 million, a 31.72% increase, with the full-year FY2025 number at -$26.5 million, up 31.72% from a year prior.
  • Interest & Investment Income hit -$5.3 million in Q4 2025 for Bioventus, up from -$6.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.9 million in Q2 2021 to a low of -$10.6 million in Q3 2023.
  • Median Interest & Investment Income over the past 5 years was -$7.4 million (2022), compared with a mean of -$6.0 million.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 220.79% in 2021 and later tumbled 725.42% in 2023.
  • Bioventus' Interest & Investment Income stood at -$960000.0 in 2021, then tumbled by 669.69% to -$7.4 million in 2022, then tumbled by 39.13% to -$10.3 million in 2023, then increased by 12.48% to -$9.0 million in 2024, then soared by 41.02% to -$5.3 million in 2025.
  • The last three reported values for Interest & Investment Income were -$5.3 million (Q4 2025), -$6.2 million (Q3 2025), and -$7.5 million (Q2 2025) per Business Quant data.